pyridinolcarbamate has been researched along with Cirrhoses, Experimental Liver in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delbrück, A | 1 |
1 other study available for pyridinolcarbamate and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
[The effect of pyridinolcarbamate on the synthesis of glycosaminoglycans and collagen in connective tissue in experimental induced liver cirrhosis in rats (author's transl)].
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bilirubin; Chromat | 1974 |